NS
VKTX icon

NBC Securities’s Viking Therapeutics VKTX Stock Holding History

NBC Securities’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.8K Buy
2,378
+116
+5% +$3.75K 0.01% 1105
2026
Q1 		$73.6K Hold
2,262
– – 0.01% 1181
2025
Q4 		$79.6K Sell
2,262
-165
-7% -$5.85K 0.01% 1160
2025
Q3 		$63.8K Sell
2,427
-146
-6% -$4.36K ﹤0.01% 1224
2025
Q2 		$68K Buy
2,573
+351
+16% +$9.24K 0.01% 1207
2025
Q1 		$53K Buy
2,222
+2,221
+222,100% +$70.2K ﹤0.01% 1155
2024
Q4 		$52 Sell
1
-1,130
-100% -$64.4K ﹤0.01% 1034
2024
Q3 		$71K Buy
1,131
+113
+11% +$6.63K 0.01% 1076
2024
Q2 		$53K Buy
+1,018
New +$66.7K ﹤0.01% 1128

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

NBC Securities's VKTX Position: Q2 2026 in Review

NBC Securities increased its Viking Therapeutics (VKTX) stake by 5.1% in Q2 2026, buying an estimated $3.75K and bringing the position to 2,378 shares worth $92.8K. The position accounts for 0.01% of the portfolio, ranked #1105.

NBC Securities first reported a position in VKTX in Q2 2024 and has held it in 9 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • NBC Securities held 2,378 shares of Viking Therapeutics worth $92.8K as of Q2 2026.
  • NBC Securities bought 116 Viking Therapeutics shares in Q2 2026, an estimated $3.75K.
  • Viking Therapeutics made up 0.01% of NBC Securities's portfolio in Q2 2026, its #1105 holding.
  • NBC Securities first reported a position in Viking Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.